Eeyarestatin 1 interferes with both retrograde and anterograde intracellular trafficking pathways. (2011)
Attributed to:
The use of newly discovered inhibitors to identify novel components of the ER associated degradation pathway.
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0022713
PubMed Identifier: 21799938
Publication URI: http://europepmc.org/abstract/MED/21799938
Type: Journal Article/Review
Volume: 6
Parent Publication: PloS one
Issue: 7
ISSN: 1932-6203